Review of nearly 500 patient cases shows surgery benefits for congenital hyperinsulinism

May 7, 2018, Children's Hospital of Philadelphia

A review of nearly 500 cases of infants with severe congenital hyperinsulinism who underwent partial or near-total removal of their pancreas for persistent hypoglycemia at Children's Hospital of Philadelphia (CHOP) showed that surgeons can cure virtually all patients with the focal, or localized, form of the rare genetic disease. Surgery also can prevent complications in patients with the diffuse form, in which defective insulin-producing cells occur throughout the pancreas.

The review, first presented during the 2018 American Pediatric Surgical Association Annual Meeting, represents the world's largest single-center case series of with congenital HI.

"Over the course of the past two decades, The Congenital Hyperinsulinism Center at CHOP has taken a multidisciplinary approach that combines pediatric endocrinology, genetics, radiology, pathology, and surgery to diagnose and treat appropriately selected HI patients with pancreatectomy," said N. Scott Adzick, MD, Surgeon-in-Chief at Children's Hospital of Philadelphia and lead author of this paper. "Since most children's hospitals only encounter one or two cases per year, it is important that children with this rare disease receive medical care from an experienced team."

In congenital HI, inherited mutations disrupt the insulin-secreting beta cells, allowing insulin levels to become excessive, essentially making it the opposite of diabetes. This oversecretion causes persistent hypoglycemia (low blood sugar) and can lead to irreversible brain damage or death if not treated properly.

"Many families experience weeks of stress before they are transferred to CHOP for definite treatment," said Diva De León-Crutchlow, MD, a pediatric endocrinologist and Director of CHOP's Congenital Hyperinsulinism Center and co-author of the paper.

Patients with focal disease can be cured with a selective partial pancreatectomy, which removes only the affected portion of the pancreas and preserves the normal pancreas. Alternatively, patients with diffuse disease often require a near-total pancreatectomy in which surgeons remove at least 95 percent of the pancreas. This surgery helps control the hypoglycemia but increases the patient's long-term risk of developing diabetes. There are also a variety of atypical cases of HI that require special considerations.

According to this review, 47 percent of patients with surgically treated HI between 10 and 20 years old have diabetes, and all patients who developed diabetes had near-total pancreatectomies to treat diffuse HI. The team is studying a variety of aspects of the disease to better treat patients with diffuse HI. In addition to studying the underlying genetic causes of HI, they are also studying how the disease functions at a molecular level with the goal of developing targeted therapies that would reduce the need for surgery.

"We are actively pursuing clinical trials for new therapies that may improve the quality of life for patients with diffuse HI, including an investigational drug called exendin-(9-39) that can increase fasting blood glucose in these patients," De Leon-Crutchlow said. "The therapy has been shown to be effective in older patients and we are currently studying its effects in younger patients."

The study team is also examining the use of modern technology for monitoring and treating hypo- and hyperglycemia in children and adults with hyperinsulinism.

"Our team's approach is able to distinguish focal from diffuse HI, localize focal lesions, and cure almost all focal patients with a partial pancreatectomy, and while we cannot cure diffuse HI, we can help prevent brain damage and severe hypoglycemia commonly associated with the ," said Adzick. "When all is said and done, the children treated with our approach to focal HI have been able to lead normal lives and not worry about the effects of this rare condition."

Explore further: In pilot study, a peptide controls blood sugar in people with congenital hyperinsulinism

More information: N. Scott Adzick, et al, "Surgical Treatment of Congenital Hyperinsulinism: Results from 495 Pancreatectomies in Neonates and Children," American Pediatric Surgical Association Annual Meeting. May 4, 2018; Palm Desert, CA.

Related Stories

In pilot study, a peptide controls blood sugar in people with congenital hyperinsulinism

August 1, 2012
A pilot study in adolescents and adults has found that an investigational drug shows promise as the first potential medical treatment for children with the severest type of congenital hyperinsulinism, a rare but potentially ...

New test could identify infants with rare insulin disease

October 23, 2014
A rare form of a devastating disease which causes low blood sugar levels in babies and infants may now be recognised earlier thanks to a new test developed by researchers from The University of Manchester.

A new approach to high insulin levels

September 18, 2017
Diabetes is characterised by a deficiency of insulin. Its opposite is a condition called congenital hyperinsulinism—patients produce the hormone too frequently and in excessive quantities, even if they haven't eaten any ...

Purified fish oils could help treat rare disease affecting newborn babies

March 12, 2014
A rare and potentially lethal disease of newborn babies whose bodies make too much insulin may be treatable with fish oils, according to researchers from The University of Manchester.

Recommended for you

Clues found to early lung transplant failure

May 21, 2018
Among organ transplant patients, those receiving new lungs face a higher rate of organ failure and death compared with people undergoing heart, kidney and liver transplants. One of the culprits is inflammation that damages ...

In breakthrough, surgeon builds windpipes from arteries

May 20, 2018
Where others failed, sometimes spectacularly, French surgeon Emmanuel Martinod has helped people whose windpipes have been ravaged by cancer and other diseases to live and breathe normally again.

Blood type O patients may have higher risk of death from severe trauma

May 1, 2018
Blood type O is associated with high death rates in severe trauma patients, according to a study published in the open access journal Critical Care that involved 901 Japanese emergency care patients.

Brains, eyes, testes: off-limits for transplants?

April 28, 2018
Since the world's first successful organ transplant in 1954—a kidney—the discipline has advanced to the point where a wounded soldier could have his penis and scrotum replaced in a groundbreaking operation last month.

Emergency treatment by older surgeons linked to slightly lower death rates

April 26, 2018
Patients undergoing emergency surgery who are treated by older surgeons (aged 60 or over) have slightly lower death rates in the first few weeks after their operation than patients treated by younger surgeons (aged less than ...

Bionic suit helps paralyzed patients stand and walk again

April 25, 2018
Patients undergoing physical rehabilitation at Rush for paralyzing injuries are being aided by a robotic suit designed to help raise people to full height and walk.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.